Immunosuppressant_JJ
PG490_NN
-LRB-_-LRB-
triptolide_NN
-RRB-_-RRB-
inhibits_VBZ
T-cell_NN
interleukin-2_NN
expression_NN
at_IN
the_DT
level_NN
of_IN
purine-box\/nuclear_JJ
factor_NN
of_IN
activated_VBN
T-cells_NNS
and_CC
NF-kappaB_NN
transcriptional_JJ
activation_NN
._.

PG490_NN
-LRB-_-LRB-
triptolide_NN
-RRB-_-RRB-
is_VBZ
a_DT
diterpene_JJ
triepoxide_NN
with_IN
potent_JJ
immunosuppressive_JJ
and_CC
antiinflammatory_JJ
properties_NNS
._.

PG490_NN
inhibits_VBZ
interleukin_NN
-LRB-_-LRB-
IL_NN
-RRB-_-RRB-
-2_CD
expression_NN
by_IN
normal_JJ
human_JJ
peripheral_JJ
blood_NN
lymphocytes_NNS
stimulated_VBN
with_IN
phorbol_NN
12-myristate_NN
13-acetate_NN
-LRB-_-LRB-
PMA_NN
-RRB-_-RRB-
and_CC
antibody_NN
to_TO
CD3_NN
-LRB-_-LRB-
IC50_NN
of_IN
10_CD
ng\/ml_NN
-RRB-_-RRB-
,_,
and_CC
with_IN
PMA_NN
and_CC
ionomycin_NN
-LRB-_-LRB-
Iono_NN
,_,
IC50_NN
of_IN
40_CD
ng\/ml_NN
-RRB-_-RRB-
._.

In_IN
Jurkat_NN
T-cells_NNS
,_,
PG490_NN
inhibits_VBZ
PMA\/Iono-stimulated_JJ
IL-2_NN
transcription_NN
._.

PG490_NN
inhibits_VBZ
the_DT
induction_NN
of_IN
DNA_NN
binding_NN
activity_NN
at_IN
the_DT
purine-box_NN
\/_:
antigen_NN
receptor_NN
response_NN
element_NN
-LRB-_-LRB-
ARRE_NN
-RRB-_-RRB-
\/_:
nuclear_JJ
factor_NN
of_IN
activated_VBN
T-cells_NNS
-LRB-_-LRB-
NF-AT_NN
-RRB-_-RRB-
target_NN
sequence_NN
but_CC
not_RB
at_IN
the_DT
NF-kappaB_NN
site_NN
._.

PG490_NN
can_MD
completely_RB
inhibit_VB
transcriptional_JJ
activation_NN
at_IN
the_DT
purine-box\/ARRE\/NF-AT_NN
and_CC
NF-kappaB_NN
target_NN
DNA_NN
sequences_NNS
triggered_VBN
by_IN
all_DT
stimuli_NNS
examined_VBN
-LRB-_-LRB-
PMA_NN
,_,
PMA\/Iono_NN
,_,
tumor_NN
necrosis_NN
factor-alpha_NN
-RRB-_-RRB-
._.

PG490_NN
also_RB
inhibits_VBZ
PMA-stimulated_JJ
activation_NN
of_IN
a_DT
chimeric_JJ
transcription_NN
factor_NN
in_IN
which_WDT
the_DT
C-terminal_JJ
TA1_NN
transactivation_NN
domain_NN
of_IN
NF-kappaB_NN
p65_NN
is_VBZ
fused_VBN
to_TO
the_DT
DNA_NN
binding_NN
domain_NN
of_IN
GAL4_NN
._.

In_IN
16HBE_NN
human_JJ
bronchial_JJ
epithelial_JJ
cells_NNS
,_,
IL-8_NN
expression_NN
is_VBZ
regulated_VBN
predominantly_RB
by_IN
NF-kappaB_NN
,_,
and_CC
PG490_NN
but_CC
not_RB
cyclosporin_NN
A_NN
can_MD
completely_RB
inhibit_VB
expression_NN
of_IN
IL-8_NN
._.

The_DT
mechanism_NN
of_IN
PG490_NN
inhibition_NN
of_IN
cytokine_NN
gene_NN
expression_NN
differs_VBZ
from_IN
cyclosporin_NN
A_NN
and_CC
involves_VBZ
nuclear_JJ
inhibition_NN
of_IN
transcriptional_JJ
activation_NN
of_IN
NF-kappaB_NN
and_CC
the_DT
purine-box_JJ
regulator_NN
operating_VBG
at_IN
the_DT
ARRE\/NF-AT_NN
site_NN
at_IN
a_DT
step_NN
after_IN
specific_JJ
DNA_NN
binding_NN
._.

